Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection.
作者信息
Thelwall Simon, Aiano Felicity, Harman Katie, Dabrera Gavin, Ladhani Shamez N
机构信息
COVID-19 National Epidemiology Cell, UK Health Security Agency, London, NW9 5DF, UK.
Immunisation Division, UK Health Security Agency, London, UK.
出版信息
Lancet Child Adolesc Health. 2022 May;6(5):e16-e17. doi: 10.1016/S2352-4642(22)00096-7. Epub 2022 Mar 29.
Abstract
摘要
相似文献
1
Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection.
Lancet Child Adolesc Health. 2022 May;6(5):e16-e17. doi: 10.1016/S2352-4642(22)00096-7. Epub 2022 Mar 29.
2
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
3
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
Lancet Infect Dis. 2021 Nov;21(11):1507-1517. doi: 10.1016/S1473-3099(21)00290-5. Epub 2021 Jun 23.
4
COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study.
Lancet Healthy Longev. 2022 Sep;3(9):e589-e598. doi: 10.1016/S2666-7568(22)00166-0. Epub 2022 Aug 1.
5
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.
Lancet Infect Dis. 2022 Jul;22(7):967-976. doi: 10.1016/S1473-3099(22)00154-2. Epub 2022 Apr 22.
6
Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality.
Infection. 2023 Oct;51(5):1357-1367. doi: 10.1007/s15010-023-01996-y. Epub 2023 Feb 14.
7
Long-term multi-systemic complications after SARS-CoV-2 Omicron and Delta infection in children: a retrospective cohort study.
Clin Microbiol Infect. 2025 Apr;31(4):616-624. doi: 10.1016/j.cmi.2024.12.017. Epub 2024 Dec 26.
8
COVID-19 vaccine effectiveness and uptake in a national cohort of English children and young people with life-limiting neurodisability.
Arch Dis Child. 2025 Jan 24;110(2):158-164. doi: 10.1136/archdischild-2024-327293.
9
Risk factors for SARS-CoV-2 infection and hospitalisation in children and adolescents in Norway: a nationwide population-based study.
BMJ Open. 2022 Mar 11;12(3):e056549. doi: 10.1136/bmjopen-2021-056549.
10
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
Euro Surveill. 2022 Jan;27(4). doi: 10.2807/1560-7917.ES.2022.27.4.2200077.
引用本文的文献
1
Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS).
J Infect Dis. 2025 Apr 15;231(4):e734-e742. doi: 10.1093/infdis/jiaf001.
2
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study.
Nat Commun. 2024 Mar 11;15(1):2173. doi: 10.1038/s41467-024-46497-0.
3
The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis.
Front Immunol. 2023 Aug 25;14:1159269. doi: 10.3389/fimmu.2023.1159269. eCollection 2023.
4
Pediatric Hospitalizations and ICU Admissions Due to COVID-19 and Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 in England.
JAMA Pediatr. 2023 Jul 31;177(9):947-55. doi: 10.1001/jamapediatrics.2023.2357.
5
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.
BMJ Paediatr Open. 2022 Oct;6(1). doi: 10.1136/bmjpo-2022-001657.
6
COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
PLoS Med. 2022 Nov 8;19(11):e1004118. doi: 10.1371/journal.pmed.1004118. eCollection 2022 Nov.
7
SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021.
J Korean Med Sci. 2022 Oct 31;37(42):e303. doi: 10.3346/jkms.2022.37.e303.
8
Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta Variant.
Children (Basel). 2022 May 3;9(5):652. doi: 10.3390/children9050652.
9
The role of children in household transmission of COVID-19: a systematic review and meta-analysis.
Int J Infect Dis. 2022 Sep;122:266-275. doi: 10.1016/j.ijid.2022.05.016. Epub 2022 May 11.
本文引用的文献
1
Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta Variant.
Children (Basel). 2022 May 3;9(5):652. doi: 10.3390/children9050652.
2
Effectiveness of BNT162b2 against COVID-19 in adolescents.
Lancet Infect Dis. 2022 May;22(5):581-583. doi: 10.1016/S1473-3099(22)00177-3. Epub 2022 Mar 21.
3
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
Lancet Infect Dis. 2022 Jan;22(1):35-42. doi: 10.1016/S1473-3099(21)00475-8. Epub 2021 Aug 27.
4
Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis.
JAMA Pediatr. 2021 Feb 1;175(2):143-156. doi: 10.1001/jamapediatrics.2020.4573.
Zotero 插件